Tajti, Peter
Xenogiannis, Iosif
Karmpaliotis, Dimitris
Alaswad, Khaldoon
Jaffer, Farouc A.
Nicholas Burke, M.
Ungi, Imre
Brilakis, Emmanouil S.
Article History
First Online: 22 October 2018
Compliance with Ethical Standards
:
: Dimitri Karmpaliotis declares speaker honoraria from Abbott Vascular, Medtronic, Boston Scientifiic, and Vascular Solutions.Khaldoon Alaswad declares consulting fees from Terumo and Boston Scientific; consultant, no financial, Abbott Laboratories.Farouc A. Jaffer reports the following: Consultant: Abbott Vascular, Boston Scientific, Siemens and Philips. Research grant: Canon, Siemens, and National Institutes of Health.M. Nicholas Burke declares consulting and speaker honoraria from Abbott Vascular and Boston Scientific.Emmanouil S. Brilakis declares consulting/speaker honoraria from Abbott Vascular, ACIST, Amgen, Asahi, CSI, Elsevier, GE Healthcare, Medicure, and Nitiloop; research support from Boston Scientific and Osprey. Board of Directors: Cardiovascular Innovations Foundation. Board of Trustees: Society of Cardiovascular Angiography and Interventions. American Heart Association (associate editor <i>Circulation</i>). MHI Ventures, shareholder.Peter Tajti, Iosif Xenogiannis, and Imre Ungi declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.